Previous 10 | Next 10 |
2023-07-11 09:00:00 ET Summary InMode's valuations have been discounted drastically compared to its 3Y means and its peers, suggesting its overly depressed price target of $48.30. However, we believe an upward revision to P/E of 18x is warranted, suggesting a more optimistic long-...
2023-07-10 10:00:00 ET With market capitalizations ranging from $3.6 billion to $7.2 billion, these four mid-cap stocks offer multi-bagger potential. Doximity (NYSE: DOCS) and Progyny (NASDAQ: PGNY) are home to first-mover advantages -- giving them a head start over their co...
2023-06-26 07:59:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Buying and holding stocks for the long term takes up less time and can produce solid returns. Instead of looking at technical indicators and studying the market every day, investors can focus...
2023-06-14 14:36:53 ET InMode ( NASDAQ: INMD ) ticked up 0.5% amid a positive mention from an investor about the aesthetics company. InMode ( INMD ) was pitched by Aureus Asset Management's Karen Firestone as a "final trade" on CNBC's "Halftime" show. "There are a...
2023-06-06 23:47:13 ET Summary InMode is a leader in the niche industry of minimally invasive medical treatment solutions, with strong brand recognition and a growing market presence. The company has an experienced leadership team, impressive financials, including high gross margi...
2023-06-05 11:00:00 ET Summary InMode stock has underperformed the S&P 500 significantly since our previous update, as we urged investors to be cautious. INMD has failed to clear the $40 resistance level decisively since August 2022. Its tepid forward guidance indicates that t...
2023-05-24 13:57:04 ET The Russell 3000 index will have a new look on June 26, after the market opens, when 286 securities will be added and 179 securities will be deleted as part of the annual reconstitution. Following are some notable healthcare companies which will be added an...
2023-05-18 09:30:00 ET Are you looking for a stock to buy that's generating strong growth and trading at a low valuation? It's not easy to find that combination given the current economic conditions, but one that could fit the bill is InMode (NASDAQ: INMD) . The business has bee...
InMode to Present at Upcoming Investor Conferences and Events PR Newswire YOKNEAM, Israel , May 17, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will participate at ...
2023-05-10 05:30:00 ET Teladoc Health (NYSE: TDOC) and InMode (NASDAQ: INMD) both operate in high-growth industries. Teladoc is a leader in telemedicine. InMode specializes in selling devices in the minimally invasive and non-invasive aesthetics market. Both of these areas a...
News, Short Squeeze, Breakout and More Instantly...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...